Patents Assigned to HR Pharmaceuticals, Inc.
  • Publication number: 20240165372
    Abstract: A discrete catheter assembly as provided includes a containment unit and an outer protector layer. The outer protector layer has a rear cap, which is fitted over the shell base of the outer protector layer in which the front cap of the outer protector layer is removed while the rear cap of the outer protector layer is moved in a first direction away from the dispenser, then moved in a second direction to permit a movement of the catheter of the containment unit towards the dispenser.
    Type: Application
    Filed: November 22, 2022
    Publication date: May 23, 2024
    Applicant: HR Pharmaceuticals, Inc.
    Inventors: Matt Hanna, Colby Wiesman, Chris Wiesman, Randy Golden, Sara Zebouni Miars, John Golden
  • Publication number: 20220118115
    Abstract: A coupling agent composition is provided and includes a plurality of non-toxic components in an amount equal to or greater than 97 weight percent (wt %). The coupling agent composition includes a carrier of water, at least one water soluble polyol selected from the group consisting of propanediol, pentylene glycol, and butylene glycol, a thickening agent having a naturally derived soluble polymer additive selected from a group consisting of xanthan gum, carrageenan, guar, locust bean, sodium hyaluronate, sodium alginate, acacia, tara gum, tamarind seed, succinoglycan, scleroglucan, and mannan, and a balance of incidental impurities.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 21, 2022
    Applicant: HR Pharmaceuticals, Inc.
    Inventors: Jon Wiesman, George Deckner
  • Publication number: 20200306388
    Abstract: A coupling agent composition is provided and includes a plurality of non-toxic components, a neutralizing agent, and a chelating agent. The plurality of non-toxic components is derived from one or more natural resource materials and is an amount equal to or greater than 97 weight percent (wt %) of the composition. The plurality of non-toxic components includes a carrier, at least one water soluble polyol selected from the group consisting of propanediol, pentylene glycol, and butylene glycol in an amount of from 9.00 to 11.00 wt %, and a thickening agent of 0.10 to 3.00 wt % having a naturally derived soluble polymer additive selected from a group consisting of xanthan gum, carrageenan, guar, locust bean, sodium hyaluronate, sodium alginate, acacia, tara gum, tamarind seed, succinoglycan, scleroglucan, and mannan in an amount of 0.50-3.00 wt %.
    Type: Application
    Filed: April 14, 2020
    Publication date: October 1, 2020
    Applicant: HR Pharmaceuticals, Inc.
    Inventors: Jon Wiesman, George Deckner
  • Publication number: 20180360415
    Abstract: An ultrasound coupling gel container is provided and includes a flexible body having front wall, back wall, an outlet end, a planar bottom gusset, and a dispensing assembly. The back wall is positioned adjacent and opposes the front wall. The back wall is sealed to the front wall along a periphery thereof and provides a cavity receiving section. An outlet end is formed from a front wall top section and a back wall bottom section. The planar bottom gusset includes a central portion formed from sealed peripheral edge portions along the front wall and of the back wall. The dispensing assembly is sealed to a peripheral edge of the front wall and of the back wall at the outlet end of the flexible body.
    Type: Application
    Filed: June 15, 2017
    Publication date: December 20, 2018
    Applicant: HR Pharmaceuticals, Inc.
    Inventor: Ryan Dohm
  • Publication number: 20180104363
    Abstract: A coupling agent composition is provided and includes a plurality of non-toxic components and a thickening agent. The plurality of non-toxic components is derived from one or more natural resource materials and is an amount equal to or greater than 97 weight percent (wt %) of the composition. The thickening agent is provided in an amount of 0.05-5.00 wt % of the composition. The balance of the composition is incidental impurities.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 19, 2018
    Applicant: HR Pharmaceuticals, Inc.
    Inventors: Jon Wiesman, George Deckner